The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1345
August 23, 2010
View Complete Issue         Table of Contents 2019 
An Expanded Pneumococcal Vaccine (Prevnar 13) for Infants and Children
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
An Expanded Pneumococcal Vaccine (Prevnar 13) for Infants and Children
August 23, 2010 (Issue: 1345)
The FDA has licensed a 13-valent conjugate pneumococcal vaccine (PCV13; Prevnar 13 – Pfizer) for the prevention of invasive pneumococcal disease (IPD) in infants and children...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: An Expanded Pneumococcal Vaccine (Prevnar 13) for Infants and Children
Article code: 1345c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.